GERM vs. OZEM ETF Comparison

Comparison of ETFMG Treatments Testing and Advancements ETF (GERM) to Roundhill GLP-1 & Weight Loss ETF (OZEM)
GERM

ETFMG Treatments Testing and Advancements ETF

GERM Description

GERM is designed to give direct exposure to the biotech companies directly engaged in the testing and treatments of infectious diseases. Focused on advancements with targeted exposure to the forefront of R&D, vaccines, therapies and testing technologies.

Grade (RS Rating)

Last Trade

$19.16

Average Daily Volume

1,248

Number of Holdings *

2

* may have additional holdings in another (foreign) market
OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$27.19

Average Daily Volume

27,613

Number of Holdings *

6

* may have additional holdings in another (foreign) market
Performance
Period GERM OZEM
30 Days 3.00% -3.44%
60 Days 3.68% 5.67%
90 Days -2.06% 0.26%
12 Months -0.17%
0 Overlapping Holdings
Symbol Grade Weight in GERM Weight in OZEM Overlap
Compare ETFs